Table 3.

Spearman's rank correlation analysis of NEAT1, MALAT1, AR, FST and IRS-2 with clinical and biochemical characteristics in PCOS patients.

Parameter	NEAT1		MALAT1		AR		FST		IRS-2
	r	P-value	r	P-value	r	P-value	r	P-value	r	P-value
BMI	0.47	0.000	−0.029	0.809	0.51	0.000	0.45	0.000	0.32	0.005
TT	0.308	0.008	0.082	0.49	0.27	0.018	0.403	0.0004	0.28	0.014
Fasting insulin	0.19	0.108	−0.105	0.37	0.302	0.009	0.33	0.004	0.18	0.12
Fasting glucose	0.17	0.14	−0.108	0.36	0.29	0.012	0.29	0.011	0.18	0.12
HOMA-IR	0.16	0.15	−0.109	0.36	0.28	0.013	0.304	0.009	0.16	0.16
Total cholesterol	0.48	0.000	−0.05	0.65	0.37	0.001	0.41	0.0003	0.32	0.005
TGs	0.28	0.014	0.02	0.85	0.38	0.0007	0.43	0.0001	0.26	0.023
HDL	−0.12	0.309	−0.12	0.27	−0.301	0.009	−0.31	0.007	−0.1	0.39
LDL	0.48	0.000	−0.07	0.53	0.35	0.002	0.41	0.0003	0.22	0.061

r: correlation coefficient, NEAT1: nuclear enriched abundant transcript 1, MALAT1: metastasis associated lung adenocarcinoma transcript 1, AR: androgen receptor, FST: follistatin, IRS-2: insulin receptor substrate-2, BMI: body mass index, TT: total testosterone, HOMA-IR: homeostasis model assessment for insulin resistance, TGs: triglycerides, HDL: high-density lipoprotein and LDL: low-density lipoprotein. Significant P-values are indicated in the table.